APA (7th ed.) Citation

Lu, E. R., Hoo, C. P. L., Cheung, H. M., Wong, I. W. C., Fung, K. F. K., Chang, S. L. Y., . . . Chan, G. C. F. (2026). End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy—Modified N7 Regimen with Dinutuximab Beta. Cancers, 18(6), 1028. https://doi.org/10.3390/cancers18061028

Chicago Style (17th ed.) Citation

Lu, Evelyn R., et al. "End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy—Modified N7 Regimen with Dinutuximab Beta." Cancers 18, no. 6 (2026): 1028. https://doi.org/10.3390/cancers18061028.

MLA (9th ed.) Citation

Lu, Evelyn R., et al. "End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy—Modified N7 Regimen with Dinutuximab Beta." Cancers, vol. 18, no. 6, 2026, p. 1028, https://doi.org/10.3390/cancers18061028.